EC Paediatrics

Research Article Volume 13 Issue 12 - 2024

Epidemiological and Clinical Characteristics of Pediatric COVID-19: A Tertiary Care Study in AlAhsa, Saudi Arabia

Yameen A AlMatawah1, Ahmed T Alomran1, Fadi Nabih Busaleh2*, Zainab Hashem Alsadah1, Heba H Alameer2, Zahra A Al-moaibid1, Heba J Alrebh1, Qasim S Alkhaleefah1, Majed J Albuali2, Nasser M AlYousef2, Abdullah E Busaleh3, Abdulhadi Al Ali3, Fatimah A Bukhamsin4 , Mustafa A. Alturki5, Abdulmohsen Abdullah Aljaziri2and Jassim Eid Alnaimi6

1Infection Control Department, Maternity and Children Hospital, Alhassa, Saudi Arabia 2Pediatrics Department, Maternity and Children Hospital, Alhassa, Saudi Arabia 3Emergency Department, AL-Jaffer Hospital Alhassa, Saudi Arabia 4Primary Health Care Center, Alhassa Cluster, Saudi Arabia 5Senior general surgery registrar, Ras Tanura Hospital 6Family physician Health cluster, Saudi Arabia

*Corresponding Author: Fadi Nabih Busaleh, Pediatric Consultant, Pediatrics Department, Maternity and Children Hospital, Alhassa, Saudi Arabia.
Received: December 18, 2024; Published: December 26, 2024



Background: The COVID-19 pandemic has raised significant concerns about its impact on children's health worldwide, with limited studies focusing on pediatric cases in Saudi Arabia. This descriptive cross-sectional study examines the epidemiological and clinical characteristics of pediatric COVID-19 cases admitted to a tertiary pediatric hospital in AlAhsa from 2nd of March 2020, until 31st of December 2020. Additionally, the study identifies risk factors associated with pediatric intensive care unit (PICU) admissions and mortality.

Method: This study included children with confirmed COVID-19 admitted to Maternity and Children Hospital in AlAhsa. Data on demographics, clinical presentations, comorbidities, and laboratory findings were collected and analyzed. Associations between these variables and outcomes such as PICU admission and mortality were assessed using IBM SPSS version 22.

Results: A total of 123 children with COVID-19 were included, with a mean age of 7.6 ± 4.9 years (range: 1 - 14 years). Males constituted 48.8% (n = 60) of cases, and 99.2% (n = 122) were Saudi nationals. Comorbidities were present in 32.2% (n = 37) of patients. Symptoms were reported in 84.6% (n = 104) of cases, with respiratory symptoms in 50.4% (n = 62) and gastrointestinal (GIT) symptoms in 45.5% (n = 56). Symptom duration ranged between 1-6 days in 61.5% (n = 64) and exceeded 15 days in 9.6% (n = 10). Fever was the most commonly reported symptom (61.8%). Additionally, 65% (n = 80) of patients tested positive for the G6PD assay. PICU admission occurred in 22.8% (n = 28) of cases. Children with GIT symptoms had a significantly higher PICU admission rate (37.5%) compared to those without GIT symptoms (10.4%, P = .001). Similarly, 75% of children with diabetes required PICU admission compared to 21.6% of others (P = .013). The overall mortality rate was 5.7% (n = 7). All mortalities occurred among PICU-admitted children, indicating a significant association between PICU admission and mortality.

Conclusion: Most pediatric COVID-19 cases presented with mild symptoms, with respiratory and gastrointestinal manifestations being the most common. Comorbidities, such as diabetes, significantly increased the likelihood of PICU admission. PICU admission emerged as a critical risk factor for mortality. Further research is needed to explore the relationship between comorbidities, disease severity, and mortality to enhance outcomes in pediatric COVID-19 cases.

 Keywords: COVID-19; Pneumonia; Respiratory Distress Syndrome; Pandemic; Corona Virus

  1. Jameela A Kari., et al. “Coronavirus disease in children: A multicenter study from the Kingdom of Saudi Arabia”. Journal of Infection and Public Health 4 (2021): 543-549.
  2. Ahmad AlGhamdi., et al. “Epidemiology, clinical characteristics and risk factors of COVID-19 among children in Saudi Arabia: a multicenter chart review study”. BMC Pediatrics 1 (2022): 86.
  3. Albuali WH., et al. “Clinical profile, risk factors and outcomes of pediatric COVID-19: a retrospective cohort multicenter study in Saudi Arabia”. BMJ Open3 (2022): e053722.
  4. AbdulAziz AlMayouf., et al. “Clinical Characteristics, Laboratory Findings, Management, and Outcome of Severe Coronavirus Disease 2019 in Children at a Tertiary Care Center in Riyadh, Saudi Arabia: A Retrospective Study”. Frontiers in Pediatrics 10 (2022).
  5. Abeer A Alnajjar., et al. “Clinical characteristics and outcomes of children with COVID-19 in Saudi Arabia”. Saudi Medical Journal 4 (2021): 391-398.
  6. Ansel Hoang., et al. “COVID-19 in 7780 pediatric patients: A systematic review”. EClinicalMedicine 24 (2020): 100433.
  7. Yousef M Alsofayan., et al. “Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study”. Journal of Infection and Public Health 7 (2020): 920-925.
  8. COVID-19 epidemiological update - 19 January 2024. WHO.
  9. K Keller., et al. “Risk factors for intensive care admission in pediatric patients with COVID-19 - results of the German nationwide inpatient sample”. European Heart Journal 1 (2022).
  10. Stephanie P Ungar., et al. “Hospital and ICU admission risk associated with comorbidities among children with covid-19 ancestral strains”. Clinical Pediatrics9 (2023).
  11. “Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study”. BMJ 370 (2020): m3249.
  12. Maroussia Roelens., et al. “Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)”. Swiss Medical Weekly4748 (2021).
  13. Eva Miranda Marwali., et al. “Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity”. BMJ Paediatrics Open 1 (2022): e001657.
  14. Jameela A Kari., et al. “Coronavirus disease in children: A multicenter study from the Kingdom of Saudi Arabia”. Journal of Infection and Public Health 4 (2021): 543-549.
  15. Stephanie P Ungar., et al. “Hospital and ICU admission risk associated with comorbidities among children with covid-19 ancestral strains”. Clinical Pediatrics9 (2023).

Fadi Nabih Busaleh., et al. "Epidemiological and Clinical Characteristics of Pediatric COVID-19: A Tertiary Care Study in AlAhsa, Saudi Arabia". EC Paediatrics 13.12 (2024): 01-11.